Valuation: Teva Pharmaceutical Industries Limited

Market Cap 46.58B 41.79B 38.64B 34.99B 65.37B 4,436B 66.16B 462B 184B 2,321B 175B 171B 7,369B P/E 2026 *
72.8x
P/E 2027 * 24x
Enterprise Value 57.91B 51.96B 48.04B 43.5B 81.28B 5,515B 82.26B 574B 229B 2,886B 217B 213B 9,162B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.18x
Free-Float
91.17%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 69 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
05/08/26 Sell

Director

-17 0.0000%
03/08/26 Exercice

Chief Technology Officer

131,066 0.0112%
03/08/26 Exercice

Head of Human Resources

38,481 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.01% - - 46.58B
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+0.34%+1.84%+30.70%+54.27% 294B
-0.45%+1.19%+2.89%+26.08% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.34%+1.39%+40.64%+76.40% 448.57B
Weighted average by Cap. +0.28%+1.50%+44.52%+89.10%

Financials

2026 *2027 *
Net sales 16.65B 14.94B 13.81B 12.51B 23.37B 1,586B 23.66B 165B 65.79B 830B 62.5B 61.18B 2,635B 17.23B 15.46B 14.3B 12.95B 24.19B 1,641B 24.48B 171B 68.08B 859B 64.67B 63.31B 2,727B
Net income 893M 801M 740M 671M 1.25B 85.01B 1.27B 8.85B 3.53B 44.48B 3.35B 3.28B 141B 2.24B 2.01B 1.86B 1.68B 3.14B 213B 3.18B 22.19B 8.84B 111B 8.39B 8.22B 354B
Net Debt 11.33B 10.17B 9.4B 8.51B 15.91B 1,079B 16.1B 112B 44.77B 565B 42.53B 41.63B 1,793B 8.27B 7.42B 6.86B 6.21B 11.61B 788B 11.75B 82.03B 32.67B 412B 31.04B 30.38B 1,309B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Teva Pharmaceutical Industries Limited